# Prednisolone Versus Colchicine for Acute Gout in Primary Care

> **NCT05698680** · PHASE4 · TERMINATED · sponsor: **University Medicine Greifswald** · enrollment: 186 (actual)

## Conditions studied

- Acute Gout

## Interventions

- **DRUG:** Prednisolone 30 mg Tablet
- **DRUG:** Colchicine 0.5 mg Oral Tablet

## Key facts

- **NCT ID:** NCT05698680
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-18
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 186 (ACTUAL)
- **Why stopped:** The study was terminated due to an inability to reach the planned sample size, despite efforts to enhance recruitment.
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05698680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05698680, "Prednisolone Versus Colchicine for Acute Gout in Primary Care". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05698680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*